Issue: May 2012
May 01, 2012
1 min read
Save

RAPID GENE

Issue: May 2012
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Researchers used novel point-of-care genetic test to identify CYP2C19*2 carriers and to assess a pharmacogenetic approach to dual antiplatelet therapy after percutaneous coronary intervention.

RAPID GENE